Related Experiment Videos
Genetic modulation of homocysteinemia
1Department of Human Genetics, McGill University, Montreal Children's Hospital, Canada. mdrr@musica.mcgill.ca
Seminars in Thrombosis and Hemostasis
|September 30, 2000
Summary
Genetic mutations in enzymes like methylenetetrahydrofolate reductase (MTHFR) can cause elevated homocysteine levels, increasing cardiovascular disease risk. Folate supplementation may help manage mild hyperhomocysteinemia caused by these common genetic variations.
Area of Science:
- Biochemistry
- Genetics
- Cardiovascular Disease Research
Background:
- Hyperhomocysteinemia is a recognized risk factor for cardiovascular disease.
- Genetic mutations can severely disrupt homocysteine metabolism (homocystinuria) or cause milder elevations.
- Understanding genetic factors is crucial for preventing and treating cardiovascular conditions linked to homocysteine levels.
Purpose of the Study:
- To explore the genetic determinants of plasma homocysteine levels.
- To investigate the role of common genetic variations in enzymes involved in homocysteine metabolism.
- To establish the clinical significance of identified genetic variants in relation to mild hyperhomocysteinemia and vascular disease.
Main Methods:
- Identification and characterization of genetic mutations in enzymes such as methylenetetrahydrofolate reductase (MTHFR), methionine synthase, and methionine synthase reductase.
- Analysis of missense mutations, including MTHFR (alanine to valine at bp 677 and glutamate to alanine at bp 1298).
- Investigation of other identified variants like those in methionine synthase (aspartate to glycine at bp 2756) and methionine synthase reductase (isoleucine to methionine at bp 66).
Main Results:
- A common missense mutation in MTHFR (bp 677) leads to mild hyperhomocysteinemia, particularly when folate levels are low.
- Folate supplementation is a potential strategy to counteract the genetic deficiency caused by the MTHFR 677 mutation.
- Several other genetic variants in MTHFR, methionine synthase, and methionine synthase reductase have been identified.
Conclusions:
- Common genetic variants in homocysteine metabolism enzymes contribute to elevated plasma homocysteine.
- The MTHFR 677 mutation highlights the interplay between genetics and nutrient status (folate) in determining homocysteine levels.
- Further research is needed to fully elucidate the clinical significance of recently identified genetic variants in mild hyperhomocysteinemia and associated vascular disease.